Saida T - Search Results

1

Matsumoto K, Saida T. Matsumoto K, et al. Among authors: saida t. Gan To Kagaku Ryoho. 2008 Oct;35(10):1645-8. Gan To Kagaku Ryoho. 2008. PMID: 18931563 Japanese.

2

Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma.

Rokuhara S, Saida T, Oguchi M, Matsumoto K, Murase S, Oguchi S. Rokuhara S, et al. Among authors: saida t. J Am Acad Dermatol. 2004 May;50(5):695-700. doi: 10.1016/j.jaad.2003.11.053. J Am Acad Dermatol. 2004. PMID: 15097952

3

[Gene therapy for patients with malignant melanoma].

Saida T, Matsumoto K, Kageshita T, Mizuno M, Yoshida J. Saida T, et al. Nihon Rinsho. 2005 Dec;63 Suppl 12:566-71. Nihon Rinsho. 2005. PMID: 16416854 Review. Japanese. No abstract available.

4

[Malignant melanoma].

Matsumoto K, Saida T. Matsumoto K, et al. Among authors: saida t. Nihon Rinsho. 2006 Jul;64(7):1321-6. Nihon Rinsho. 2006. PMID: 16838651 Review. Japanese.

5

Interferon-beta therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells.

Kubo H, Ashida A, Matsumoto K, Kageshita T, Yamamoto A, Saida T. Kubo H, et al. Among authors: saida t. Arch Dermatol Res. 2008 Jul;300(6):297-301. doi: 10.1007/s00403-008-0841-6. Epub 2008 Mar 7. Arch Dermatol Res. 2008. PMID: 18324409

6

A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes.

Matsumoto K, Kubo H, Murata H, Uhara H, Takata M, Shibata S, Yasue S, Sakakibara A, Tomita Y, Kageshita T, Kawakami Y, Mizuno M, Yoshida J, Saida T. Matsumoto K, et al. Among authors: saida t. Jpn J Clin Oncol. 2008 Dec;38(12):849-56. doi: 10.1093/jjco/hyn114. Epub 2008 Oct 22. Jpn J Clin Oncol. 2008. PMID: 18945721 Clinical Trial.

7

Nonpigmenting solitary fixed drug eruption caused by a Chinese traditional herbal medicine, ma huang (Ephedra Hebra), mainly containing pseudoephedrine and ephedrine.

Matsumoto K, Mikoshiba H, Saida T. Matsumoto K, et al. Among authors: saida t. J Am Acad Dermatol. 2003 Apr;48(4):628-30. doi: 10.1067/mjd.2003.192. J Am Acad Dermatol. 2003. PMID: 12664035

8

Skin infiltration of juvenile myelomonocytic leukemia.

Matsumoto K, Miki J, Matsuzaki S, Koike K, Saida T. Matsumoto K, et al. Among authors: saida t. J Dermatol. 2004 Sep;31(9):748-51. doi: 10.1111/j.1346-8138.2004.tb00589.x. J Dermatol. 2004. PMID: 15628322

9

Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles.

Tanaka K, Ito A, Kobayashi T, Kawamura T, Shimada S, Matsumoto K, Saida T, Honda H. Tanaka K, et al. Among authors: saida t. Int J Cancer. 2005 Sep 10;116(4):624-33. doi: 10.1002/ijc.21061. Int J Cancer. 2005. PMID: 15825167 Free article.

10

Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.

Ito A, Tanaka K, Kondo K, Shinkai M, Honda H, Matsumoto K, Saida T, Kobayashi T. Ito A, et al. Among authors: saida t. Cancer Sci. 2003 Mar;94(3):308-13. doi: 10.1111/j.1349-7006.2003.tb01438.x. Cancer Sci. 2003. PMID: 12824927 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

436 results

Search Page